细针穿刺与麦默通在 T1期乳腺癌术前诊断中应用比较

目的：探讨细针穿刺与麦默通在 T1期乳腺癌术前诊断中的效果，为乳腺癌的诊断提供依据。方法：选择本院2012年4月-2015年4月收治的有手术指征并确诊的 T1期乳腺癌患者130例进行分析，所有患者术前均进行细针穿刺与麦默通微创活检系统进行检查，观察两组检查方法的优缺点。结果：在一次性确诊 T1期乳腺癌的实际效果和准确性上，麦默通活检显著优于细针穿刺检查，差异具有统计学意义；且麦默通穿刺成功率及穿刺阳性率均显著高于细针穿刺，差异有统计学意义；但麦默通穿刺后皮下血肿及皮下淤血发生率显著高于细针穿刺，差异有统计学意义。结论：细针穿刺法简便、安全、创伤小，缺点为阳性率较低、漏诊率较高；而麦默通穿刺法具有高敏感、高特异性、微创的优点，故麦默通微创活检系统是乳腺肿块定性困难（包括细针穿刺检查阴性）时的一个安全、有效的诊断方法。

Fine-needle aspiration and Mammotome Comparison before T1 operative diagnosis of breast cancer

Objective To investigate the effect of fine needle aspiration with the Mammotome breast cancer surgery in T1 before diagnosis, provide the basis for the diagnosis of breast cancer. Methods A hospital in April 2012~April 2015 admitted to surgical indications and T1 diagnosed 130 cases of breast cancer patients were analyzed, all patients underwent preopera-tive fine needle aspiration with the Mammotome minimally invasive biopsy system inspection, inspection method to observe two disadvantages. Results In the real-time performance and accuracy of diagnosis of breast cancer T1, Mammotome significantly better than fine-needle aspiration biopsy examination, the difference was significant; and Mammotome biopsy success rate and positive were significantly higher than fine-needle aspiration, the difference was significant; but Mammotome biopsy hematoma and subcutaneous congestion were significantly higher than fine-needle aspiration, the difference was significant. Conclusion Fine needle aspiration method is simple, safe, minimally invasive, the disadvantage of low positive rate, high rate of misdiag-nosis; and Mammotome biopsy method has high sensitivity, high specificity, the advantages of minimally invasive breast mass. Mammotome minimally invasive biopsy system is a safe breast lumps qualitative difficulties (including fine-needle aspiration were negative) when effective diagnostic method.